Titan Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 434.27 million compared to INR 418.34 million a year ago. Revenue was INR 439.79 million compared to INR 426.9 million a year ago. Net income was INR 65.21 million compared to INR 91.27 million a year ago. Basic earnings per share from continuing operations was INR 7.89 compared to INR 11.04 a year ago. Diluted earnings per share from continuing operations was INR 7.89 compared to INR 11.04 a year ago.
For the six months, sales was INR 781.75 million compared to INR 768.3 million a year ago. Revenue was INR 790.09 million compared to INR 780.03 million a year ago. Net income was INR 126.82 million compared to INR 166.31 million a year ago. Basic earnings per share from continuing operations was INR 15.35 compared to INR 20.13 a year ago. Diluted earnings per share from continuing operations was INR 15.35 compared to INR 20.13 a year ago.